北京地区2023—2024年秋冬季急性呼吸道感染疾病的病原体流行情况分析:以北京协和医院5556例患者为例

曹艳, 陈雨, 伊洁, 孔令君, 王子怡, 张睿, 于奇, 刘仪威, 木拉提江·买买提, 杨城林, 孙玉杰, 徐英春, 杨启文, 杜娟

曹艳, 陈雨, 伊洁, 孔令君, 王子怡, 张睿, 于奇, 刘仪威, 木拉提江·买买提, 杨城林, 孙玉杰, 徐英春, 杨启文, 杜娟. 北京地区2023—2024年秋冬季急性呼吸道感染疾病的病原体流行情况分析:以北京协和医院5556例患者为例[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2024-0529
引用本文: 曹艳, 陈雨, 伊洁, 孔令君, 王子怡, 张睿, 于奇, 刘仪威, 木拉提江·买买提, 杨城林, 孙玉杰, 徐英春, 杨启文, 杜娟. 北京地区2023—2024年秋冬季急性呼吸道感染疾病的病原体流行情况分析:以北京协和医院5556例患者为例[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2024-0529
CAO Yan, CHEN Yu, YI Jie, KONG Lingjun, WANG Ziyi, ZHANG Rui, YU Qi, LIU Yiwei, MULATIJIANG Maimaiti, YANG Chenglin, SUN Yujie, XU Yingchun, YANG Qiwen, DU Juan. Pathogenic Agents Causing Acute Respiratory Tract Infections in Beijing During Autumn and Winter of 2023 to 2024:A Study of 5,556 Patients from Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0529
Citation: CAO Yan, CHEN Yu, YI Jie, KONG Lingjun, WANG Ziyi, ZHANG Rui, YU Qi, LIU Yiwei, MULATIJIANG Maimaiti, YANG Chenglin, SUN Yujie, XU Yingchun, YANG Qiwen, DU Juan. Pathogenic Agents Causing Acute Respiratory Tract Infections in Beijing During Autumn and Winter of 2023 to 2024:A Study of 5,556 Patients from Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0529

北京地区2023—2024年秋冬季急性呼吸道感染疾病的病原体流行情况分析:以北京协和医院5556例患者为例

基金项目: 

国家重点研发计划“基于基因组的急性传染病病原体层级分析流程的建立”(2022YFC2305301)

详细信息
    作者简介:

    曹艳负责数据整理、统计分析、论文撰写;陈雨、伊洁负责研究设计、数据整理;孔令君、王子怡、张睿、于奇、刘仪威、木拉提江·买买提、杨城林、孙玉杰负责实验室操作;徐英春、杨启文、杜娟参与研究设计、论文修订与审核。

    通讯作者:

    杜娟,E-mail:dj_pumch@126.com

  • 中图分类号: R372;R561

Pathogenic Agents Causing Acute Respiratory Tract Infections in Beijing During Autumn and Winter of 2023 to 2024:A Study of 5,556 Patients from Peking Union Medical College Hospital

Funds: 

National Key Research and Development Program: Establishment of a Hierarchical Analysis Pipeline for Acute Infectious Disease Pathogens Based on Genomics(2022YFC2305301)

  • 摘要: 目的 分析北京地区秋冬季急性呼吸道感染的流行特征,为急性呼吸道感染疾病的防控和诊治提供依据。方法 采用便利抽样法,以北京协和医院2023年9月—2024年2月因急性呼吸道感染就诊的患者为研究对象。采集患者鼻咽拭子标本,采用荧光定量PCR法检测6种常见呼吸道病原体[包括甲型流感病毒( influenza A virus,FluA)、乙型流感病毒( influenza B virus,FluB )、鼻病毒( human rhinovirus ,HRV )、肺炎支原体( mycoplasmapneumoniae,MP)、呼吸道合胞病毒( respiratory syncytial virus,RSV)和腺病毒( adenovirus,ADV)]和新型冠状病毒感染情况,对病原体感染分布特征进行分析。结果 共入选符合纳入标准的患者5556例,6种常见呼吸道病原体总体阳性率为63.7%,单一病原体阳性率为54.0%,2种病原体阳性率为8.9%,3种及以上病原体阳性率为0.7%。整体检出病原体以FluA和RSV为主,阳性率依次为16.1%和15.7%; ADV、MP、HRV和FluB阳性率接近,分别为11.1%、11.1%、10.0%和10.0%。病原体总体阳性率在性别间无显著性差异,但在秋冬季节间(χ2=34.617,P<0.001 )以及儿童、中青年和老年患者间(χ2=422.38,P<0.001)存在统计学差异。其中,MP(χ2=8.647,P=0.003)、FluA(χ2=131.932,P<0.001)和HRV(χ2=174.199,P<0.001)在秋季的阳性率显著高于冬季,而FluB在冬季的阳性率显著高于秋季(χ2=287.894,P<0.001);儿童组MP、RSV、HRV和ADV的阳性率均显著高于中青年和老年患者(P均<0.001),而FluB在中青年患者中的阳性率则显著高于儿童和老年患者(P均<0.001)。6种常见呼吸道病原体在新型冠状病毒感染流行时期阳性率明显下降,表现为非同步季节性模式。结论 北京地区呼吸道病原体流行情况与年龄、季节有关,需在不同季节、针对不同重点人群开展有针对性的预防措施。
    Abstract: Objective To investigate the pathogen spectrum of acute respiratory infections in Beijing during autumn and winter of 2023 to 2024. The findings will provide valuable insights for clinical diagnosis, treatment, prevention and control of respiratory infectious diseases through epidemiological analysis. Methods This study focused on patients who visited Peking Union Medical College Hospital for acute respiratory infections from September 2023 to February 2024 by convenience sampling.We used fluorescence quantitative PCR to detect six respiratory pathogens, namely influenza A virus (FluA), influenza B virus (FluB), Human rhinovirus (HRV), Mycoplasma pneumoniae (MP), respiratory syncytial virus (RSV), and adenovirus (ADV), in 5556 respiratory tract samples collected from patients with respiratory tract infections. Additionally, we analyzed the distribution of pathogen infections by combining the results with COVID-19 infections during the same period. Results Among the 5556 samples, the overall positive rate was 63.7%. The positive rates for single pathogen infections, dual pathogen infections, and infections with three or more pathogens were 54.0%, 8.9%, and 0.7% respectively. In terms of overall detection of pathogens, FluA and RSV were the predominant pathogens, with positive rates of 16.1% and 15.7% respectively. The positive rates for ADV, MP, HRV, and FluB were similar, at 11.1%, 11.1%, 10.0%, and 10.0% respectively. Although there was no difference in the overall pathogen positive rate between different genders and seasons, statistical differences were witnessed in the infection rates and pathogen compositions among different age groups (χ2=34.617, P<0.001, χ2=422.38, P<0.001). There were variations in the detection rates of MP, FluA, FluB, and HRV between different seasons (P<0.005). The positive rates of MP(χ2=8.647, P=0.003)、 FluA (χ2=131.932, P<0.001)和 HRV(χ2=174.199, P<0.001) were significantly higher in autumn than in winter, while FluB showed the opposite trend (χ2=287.894, P<0.001), predominantly occurring in winter. The positive rates of MP, RSV, HRV, and ADV in the pediatric group were significantly higher than those in the middleaged and elderly patients (all P <0.001), while the positive rate of FluB in middleaged patients was significantly higher than that in both children and elderly patients (P <0.001 for both). The overall number of cases infected with the six respiratory pathogens decreased significantly during the period of COVID-19 infection, exhibiting an asynchronous seasonal pattern. Conclusion The detection rate of respiratory pathogens in Beijing was related to age and season. Targeted prevention and control measures should be implemented for different populations in different seasons, and early epidemic warnings should be issued.
  • [1]

    Baker RE, Park SW, Yang W, et al. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections[J]. Proceedings of the National Academy of Sciences, 2020, 117:30547-30553.

    [2]

    Lai S, Ruktanonchai NW, Zhou L, et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China[J]. Nature, 2020, 585:410-413.

    [3] 赵林清,邓莉,曹玲,等.新型冠状病毒肺炎疫情期间北京定点排查医院儿童急性呼吸道感染的病原谱观察[J].中华儿科杂志, 2020, 58:635-639.
    [4] 姬莉莉,喻金玉,毛玉梅,等. 2015-2020年北京市怀柔区11种呼吸道病原体流行特征分析[J].首都公共卫生, 2022, 16:113-117+127.
    [5] 武利涛,姚兴伟,李宝萍,等. 2016-2018年北京地区急性呼吸道感染患者病原体流行特征分析[J].中国医药, 2019, 14:1647-1651.
    [6]

    Cai W, Köndgen S, Tolksdorf K, et al. Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023[J]. Eurosurveillance, 2024, 29:2300465. doi: 10.2807/1560-7917.ES.2024.29.13.2300465.

    [7]

    Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015:a systematic analysis for the Global Burden of Disease Study 2015[J]. The Lancet, 2016, 388:1459-1544.

    [8] 刘思家. 2017-2019年急性呼吸道腺病毒感染临床病例分析与流行特征研究[D].温州:温州医科大学, 2020.
    [9] 王方明.北京地区儿童人呼吸道腺病毒种系进化特点及腺病毒重组机制研究[D].北京:中国医学科学院, 2023.
    [10] 付玉林,董艳,李静. 2018-2019年北京市儿童社区获得性肺炎的病原学分析及临床特点[J].中国医药科学, 2022, 12:126-129.
    [11]

    Nickbakhsh S, Mair C, Matthews L, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold[J]. Proceedings of the National Academy of Sciences, 2019, 116:27142-27150.

    [12]

    Piret J, Boivin G. Viral Interference between Respiratory Viruses[J]. Emerging Infectious Diseases, 2022; 28:273-281.

计量
  • 文章访问数:  638
  • HTML全文浏览量:  12
  • PDF下载量:  34
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-07-11
  • 录用日期:  2024-08-07
  • 网络出版日期:  2024-12-09

目录

    /

    返回文章
    返回
    x 关闭 永久关闭